Description |
EYA transcriptional coactivator and phosphatase 2 |
deltex E3 ubiquitin ligase 2 |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- A body shape index ( 34021172)
- Allergic disease (asthma, hay fever and/or eczema) (age of onset) ( 32603359)
- Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis) ( 32603359)
- Allergic rhinitis ( 31361310)
- Asthma ( 32296059)
- Body fat percentage and triglycerides (pairwise) ( 33619380)
- Brain volume in infants (intracranial brain volume) ( 28763065)
- Coffee consumption ( 31046077)
- Fasting insulin ( 34059833)
- FEV1 ( 30804560)
- Glaucoma (primary open-angle) ( 33627673)
- Heel bone mineral density ( 28869591 30598549)
- High light scatter reticulocyte count ( 32888494)
- High light scatter reticulocyte percentage of red cells ( 32888494)
- Hip circumference adjusted for BMI ( 34021172)
- Hip index ( 34021172)
- Liver enzyme levels (alanine transaminase) ( 33972514)
- Lung function (FVC) ( 30804560 30061609)
- Non-del(5q) myelodysplastic syndromes ( 31738830)
- Peak expiratory flow ( 30804560)
- Reticulocyte count ( 32888494)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
- Triglyceride levels ( 32154731 32203549)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Type 2 diabetes ( 30054458 30297969)
- Visceral adipose tissue/subcutaneous adipose tissue ratio ( 22589738)
- Waist circumference adjusted for body mass index ( 34021172)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 26426971 34021172)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) ( 28448500)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist-to-hip ratio adjusted for BMI in active individuals ( 28448500)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 28448500 25673412)
|
|
Interacting Genes |
36 interacting genes:
AATK
ATOSB
BAG3
CATSPER1
CDK18
DMRTB1
DTX2
DUSP21
ENKD1
FBXO7
GNAI2
GNAZ
HGS
IQUB
LGALS4
MED25
PATZ1
PAX9
PIN1
POGZ
RBPMS
RFX2
ROR2
SIX1
SIX4
SNRPC
SPG21
SUOX
TEKT4
TEKT5
TFG
TLE5
TRAF4
TRAPPC6A
TSSK3
VPS37C
|
135 interacting genes:
ABHD11
ABHD16A
ACTMAP
ALKBH4
ANAPC11
ANTKMT
ARID5A
ARMC7
ARNT2
BCL2L11
BICRAL
BOLA2-SMG1P6
C10orf55
C1orf94
C22orf39
CCDC57
CFAP68
CIMIP1
CLPP
COA6
COQ8A
DAZAP2
DOK3
DTX1
DTX3
ECM1
ECSIT
EIF4ENIF1
EIF4G1
EYA2
FAM168A
FCRL4
FHL2
FHL5
FOXI1
FTO
GLYCTK
GOLGA2
H3C1
HDC
HGS
HLX
HOXA1
HOXB2
HOXD12
HPCA
HPCAL1
HPCAL4
HSFY1
HSFY2
IKZF3
KANK2
KLC3
KLHDC7B
KRTAP11-1
KRTAP13-3
KRTAP15-1
KRTAP19-1
KRTAP19-6
KRTAP19-7
KRTAP26-1
KRTAP6-1
KRTAP7-1
KRTAP8-1
LASP1
LNX1
LRP2BP
MBD3L1
MDC1
MED19
MSS51
MVP
MXRA8
NCALD
NCS1
NHLRC4
NIF3L1
NME4
NOTCH1
OIP5
PARP1
PARP10
PAX5
PLEKHF2
PLEKHG4
PLSCR1
POGZ
PRR32
PRR34
PSMB4
QARS1
RBM11
RBPMS
RFX6
RHOXF2
RIMBP3
RUNX1
RUNX2
RUNX3
RUSC1
SAXO4
SEC22A
SEC23A
SEC23B
SEPSECS
SLC67A1-AS
SOHLH1
SPAG8
STX12
SUMO1
TBX15
TEKT5
TENT2
TMEM42
TRIB3
TRIM35
TRIM54
TRIP13
TRIP6
UBC
UBE2D1
UBE2D2
UBE2D3
UBE2D4
UBQLN4
USP54
VGLL3
VSNL1
ZNF34
ZNF503
ZNF620
ZNF641
ZNF764
ZNF774
ZNF85
|
Entrez ID |
2139 |
113878 |
HPRD ID |
09041 |
16841 |
Ensembl ID |
ENSG00000064655
|
ENSG00000091073
|
Uniprot IDs |
E7ETN2
O00167
|
Q86UW9
|
PDB IDs |
3GEB
3HB0
3HB1
4EGC
5ZMA
7F8G
7F8H
|
6IR0
6Y22
6Y2X
6Y3J
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|